Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy
- 1 November 1996
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 50 (5), 1641-1650
- https://doi.org/10.1038/ki.1996.480
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Microalbuminuria: prognostic implicationsCurrent Opinion in Nephrology and Hypertension, 1996
- Long-term Renoprotective Effect of Angiotensin-converting Enzyme Inhibition in Non—insulin-dependent Diabetes MellitusArchives of Internal Medicine, 1996
- Angiotensin converting enzyme inhibitors and calcium antagonists alone or combined: does the progression of diabetic renal disease differ?Journal Of Hypertension, 1995
- Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy.Journal of Clinical Investigation, 1995
- Remission of nephrotic range proteinuria in type I diabetesKidney International, 1994
- The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic NephropathyNew England Journal of Medicine, 1993
- Treatment of arterial hypertension in diabetic humans: Importance of therapeutic selectionKidney International, 1992
- Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.BMJ, 1991
- Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy.BMJ, 1990
- Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy.BMJ, 1989